Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
spironolactone	O
/	O
atorvastatin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fatigue	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
This	O
is	O
a	O
___	O
woman	O
with	O
a	O
history	O
of	O
type	O
1	O
diabetes,	O
autoimmune	O
cirrhosis,	O
hypertension,	O
hyperlipidemia,	O
RLE	O
amputation	O
with	O
multiple	O
prior	O
admissions	O
for	O
UTI,	B-Urinary_tract_infection
most	O
recently	O
discharged	O
on	O
___,	O
who	O
presents	O
with	O
2	O
days	O
of	O
vomiting	O
and	O
AMS.	B-Delirium
Ms.	O
___	O
caregivers	O
have	O
noted	O
that	O
she	O
has	O
not	O
returned	O
to	O
her	O
normal	O
state	O
of	O
health	O
since	O
her	O
prior	O
hospitalization.	O
However,	O
she	O
worsened	O
from	O
her	O
post-discharge	O
baseline	O
over	O
the	O
5	O
days	O
prior	O
to	O
admission.	O
She	O
has	O
had	O
poor	O
PO	O
intake	O
and	O
appetite	O
for	O
the	O
past	O
5	O
days,	O
and	O
for	O
the	O
past	O
2	O
days	O
has	O
been	O
more	O
lethargic	O
and	O
less	O
conversant	O
with	O
4	O
episodes	O
of	O
non-bloody	B-Upper_gastrointestinal_haemorrhage
vomiting.	B-Upper_gastrointestinal_haemorrhage
She	O
has	O
24	O
hour	O
home	O
health	O
aide	O
support	O
and	O
___	O
services	B-Has_carers
at	O
home	O
___	O
manages	O
her	O
___	O
noted	O
no	O
fevers	O
at	O
home,	O
but	O
decreased	O
urine	O
output,	O
and	O
BPs	O
in	O
170s-200s.	O
On	O
her	O
last	O
admission,	O
she	O
presented	O
with	O
AMS	B-Delirium
and	O
was	O
found	O
to	O
have	O
a	O
bilateral	O
pyelonephritis	B-Urinary_tract_infection
and	O
improved	O
with	O
treatment	O
with	O
meropenem,	O
which	O
was	O
switched	O
to	O
Bactrim	O
when	O
sensitivities	O
returned.	O
She	O
was	O
discharged	O
on	O
PO	O
Bactrim.	O
On	O
the	O
prior	O
admission	O
(discharged	O
___,	O
she	O
had	O
been	O
admitted	O
for	O
hepatic	O
encephalopathy	B-Delirium
and	O
UTI.	B-Urinary_tract_infection
She	O
has	O
an	O
permanent	O
catheter	O
that	O
that	O
was	O
placed	O
during	O
her	O
admission	O
in	O
___.	O
She	O
was	O
seen	O
by	O
uro-gyn	O
in	O
___	O
who	O
started	O
prophylactic	O
abx	O
(Nitrofurantoin	O
100	O
mg	O
PO).	O
Per	O
prior	O
notes,	O
the	O
catheter	O
has	O
remained	O
in	O
place	O
per	O
patient	O
preference	O
because	O
she	O
has	O
very	O
limited	O
mobility.	O
Pertinent	O
ED	O
course	O
(including	O
exam,	O
labs,	O
imaging,	O
consults,	O
treatment):	O
Upon	O
presentation	O
to	O
the	O
ED:	O
Vitals:	O
97.7,	O
73,	O
173/83,	O
99%	O
RA	O
Labs	O
notable	O
for	O
NA	O
125,	O
K	O
5.8,	O
Cr	O
3.4;	O
WBC:	O
12.3,	O
H/H	O
9.6/___.4.	O
Repeat	O
whole	O
blood	O
K	O
found	O
to	O
be	O
5.2	O
Glucose:	O
88	O
UA:	O
+	O
WBCs,	O
+	O
leuks	O
Neurology	O
evaluated	O
the	O
patient	O
in	O
the	O
ED	O
and	O
noted	O
stable	O
anisocoria	O
from	O
prior	O
admissions	O
and	O
left	O
facial	O
droop,	O
but	O
concluded	O
that	O
her	O
presentation	O
is	O
most	O
consistent	O
with	O
delirium.	B-Delirium
Neurology	O
will	O
follow.	O
The	O
patient	O
received	O
1g	O
ceftriaxone,	O
glucagon,	O
1L	O
NS	O
before	O
being	O
transferred	O
to	O
the	O
floor.	O
Upon	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
reports	O
back	O
pain	O
and	O
fatigue,	O
but	O
denies	O
other	O
sources	O
of	O
discomfort.	O
She	O
notes	O
that	O
her	O
back	O
pain	O
is	O
consistent	O
with	O
her	O
usual	O
back	O
pain	O
at	O
home.	O
She	O
is	O
unable	O
to	O
say	O
if	O
she	O
is	O
better	O
from	O
prior.	O
She	O
denies	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
pain	O
with	O
urination.	O
Past	O
Medical	O
History:	O
-	O
H/o	O
DVT	O
-	O
H/o	O
stroke	O
-	O
L	O
posterior	O
limb	O
of	O
internal	O
capsule	O
and	O
lacunar	O
-	O
MI	O
___,	O
no	O
stents	O
-	O
DM	O
type	O
I.	O
Followed	O
by	O
___.	O
-	O
Peripheral	O
neuropathy	O
-	O
gastroparesis	O
-	O
HTN	O
-	O
Hyperlipidemia	O
-	O
Hypothyroidism	O
-	O
PVD/PAD	O
-	O
Autonomic	O
dysfunction,	O
orthostatic	O
hypotension	O
-	O
Barretts	O
Esophagus	O
on	O
EGD	O
___	O
-	O
Depression	O
-	O
S/p	O
right	O
BKA	O
-	O
Hiatal	O
hernia	O
-	O
sciatica	O
-	O
S/p	O
laminectomy	O
-	O
S/p	O
hysterectomy	O
-	O
CKD	O
-	O
Cirrhosis	O
(autoimmune	O
presumably	O
secondary	O
to	O
statin	O
use)	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
-	O
coronary	O
artery	O
disease	O
with	O
MI	O
in	O
her	O
___,	O
died	O
at	O
age	O
___.	O
Father	O
-	O
coronary	O
artery	O
disease	O
with	O
MI	O
in	O
her	O
___,	O
died	O
at	O
age	O
___.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
98.2,	O
175/74,	O
79,	O
14,	O
95%	O
on	O
RA	O
GENERAL:	O
ill	O
appearing	O
older	O
woman	O
lying	O
in	O
bed,	O
responds	O
appropriately	O
(but	O
intermittently)	O
to	O
questions	O
with	O
one	O
word	O
sentences	O
ENT:	O
no	O
maxillary,	O
supraclavicular,	O
or	O
cervical	O
lymphadenopathy	O
CV:	O
RRR,	O
no	O
rubs,	O
gallops,	O
___	O
systolic	O
murmur	O
loudest	O
at	O
RUSB	O
RESP:	O
breathing	O
unlabored,	O
(anterior	O
exam)	O
lungs	O
clear	O
to	O
auscultation,	O
minimal	O
air	O
movement	O
GI:	O
abdomen	O
soft,	O
tender	O
diffusely	O
but	O
no	O
peritoneal	O
signs,	O
distended,	O
tympanic	O
to	O
palpation,	O
bowel	O
sounds	O
hypoactive	O
but	O
present	O
GU:	O
foley	O
catheter	O
in	O
place	O
draining	O
light	O
yellow	O
urine	O
MSK:	O
RLE	O
above	O
knee	O
amputation;	O
left	O
foot	O
tender	O
to	O
palpation	O
SKIN:	O
ecchymoses	O
on	O
lower	O
abdomen,	O
hard	O
nodule	O
on	O
medial	O
left	O
calf	O
NEURO:	O
R	O
pupil	O
4mm	O
and	O
irregular,	O
L	O
pupil	O
2mm;	O
extraocular	O
eye	O
movements	O
intact	O
without	O
nystagmus,	O
left	O
facial	O
droop	O
with	O
facial	O
sensation/movement	O
intact,	O
shoulder	O
shrug	O
and	O
head	O
turn	O
intact,	O
no	O
tongue	O
or	O
uvula	O
deviation,	O
moves	O
all	O
four	O
extremities	O
purposefully	O
PSYCH:	O
flat	O
affect	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
======================	O
VITALS:	O
T	O
97.7	O
HR	O
63BP	O
170/67	O
RR	O
16O2	O
99%	O
RA	O
GENERAL:	O
NAD,	O
sitting	O
upright	O
in	O
bed	O
HEENT:	O
anisocoria	O
(left	O
pupil	O
2mm,	O
right	O
3mm	O
reactive	O
to	O
light),	O
EOMI,	O
MMM	O
NECK:	O
supple,	O
no	O
LAD	O
CV:	O
RRR,	O
S1/S2,	O
III/VI	O
systolic	O
murmur	O
LUSB	O
RESP:	O
poor	O
inspiratory	O
effort,	O
clear	O
in	O
anterior	O
fields	O
GI:	O
soft,	O
non-distended,	O
non-tender,	O
normoactive	O
BS	O
NEURO:	O
awake,	O
alert,	O
attentive,	O
oriented	B-Delirium
x3,	B-Delirium
residual	O
LLE	O
weakness	O
EXT:	O
right	O
AKA,	O
LLE	O
warm,	O
well	O
perfused,	O
trace	O
pedal	O
edema,	O
tender,	O
left	O
hand	O
contracture	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
=============	O
___	O
04:15PM	O
WBC-12.3*#	O
RBC-3.20*	O
HGB-9.6*	O
HCT-29.4*	O
MCV-92	O
MCH-30.0	O
MCHC-32.7	O
RDW-14.8	O
RDWSD-49.9*	O
___	O
04:15PM	O
NEUTS-76.0*	O
LYMPHS-10.4*	O
MONOS-6.9	O
EOS-5.4	O
BASOS-0.6	O
IM	O
___	O
AbsNeut-9.32*	O
AbsLymp-1.28	O
AbsMono-0.84*	O
AbsEos-0.66*	O
AbsBaso-0.07	O
___	O
04:15PM	O
PLT	O
COUNT-390#	O
___	O
04:15PM	O
___	O
PTT-29.3	O
___	O
___	O
04:15PM	O
GLUCOSE-88	O
UREA	O
N-43*	O
CREAT-3.4*#	O
SODIUM-125*	O
POTASSIUM-5.8*	O
CHLORIDE-92*	O
TOTAL	O
CO2-21*	O
ANION	O
GAP-17	O
___	O
04:15PM	O
ALT(SGPT)-16	O
AST(SGOT)-15	O
ALK	O
PHOS-225*	O
TOT	O
BILI-0.2	O
___	O
04:15PM	O
LIPASE-5	O
___	O
04:30PM	O
LACTATE-1.5	O
K+-5.2*	O
___	O
04:15PM	O
cTropnT-0.05*	O
___	O
01:15PM	O
URINE	O
bnzodzpn-NEG	O
barbitrt-NEG	O
opiates-NEG	O
cocaine-NEG	O
amphetmn-NEG	O
oxycodn-NEG	O
mthdone-NEG	O
___	O
01:15PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Hazy*	O
SP	O
___	O
___	O
01:15PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-100*	O
GLUCOSE-TR*	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.5	O
LEUK-LG	O
___	O
01:15PM	O
URINE	O
RBC-128*	O
WBC-91*	O
BACTERIA-NONE	O
YEAST-MANY*	O
EPI-0	O
PERTINENT	O
LABS:	O
=============	O
___	O
10:20AM	O
BLOOD	O
WBC-5.7	O
RBC-2.53*	O
Hgb-7.5*	O
Hct-23.9*	O
MCV-95	O
MCH-29.6	O
MCHC-31.4*	O
RDW-15.3	O
RDWSD-53.0*	O
Plt	O
___	O
___	O
10:20AM	O
BLOOD	O
Glucose-206*	O
UreaN-33*	O
Creat-3.1*	O
Na-129*	O
K-4.7	O
Cl-98	O
HCO3-19*	O
AnGap-17	O
___	O
09:15AM	O
BLOOD	O
ALT-13	O
AST-13	O
AlkPhos-188*	O
TotBili-0.2	O
___	O
10:20AM	O
BLOOD	O
Calcium-10.1	O
Phos-4.3	O
Mg-2.4	O
___	O
10:00AM	O
BLOOD	O
PTH-9*	O
IMAGING	O
=======	O
ABDOMINAL	O
ULTRASOUND	O
(___)	O
IMPRESSION:	O
Limited	O
imaging	O
of	O
the	O
abdomen	O
demonstrate	O
cirrhotic	O
liver,	O
small	O
volume	O
ascites,	O
and	O
small	O
right	O
pleural	O
effusion.	O
ABDOMINAL	O
X-RAY	O
(___)	O
IMPRESSION:	O
Dilated	O
colon	O
which	O
is	O
filled	O
with	O
a	O
significant	O
amount	O
of	O
air	O
and	O
stool.	O
No	O
small-bowel	O
obstruction.	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
W/O	O
CONTRAST	O
(___)	O
IMPRESSION:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	O
Brief	O
Hospital	O
Course:	O
___	O
female	O
with	O
h/o	O
cirrhosis	O
d/t	O
autoimmune	O
hepatitis,	O
DM1,	O
CKD,	O
and	O
multiple	O
admissions	O
for	O
recurrent	O
UTI	B-Urinary_tract_infection
admitted	O
for	O
AMS	B-Delirium
thought	O
to	O
be	O
secondary	O
to	O
long-acting	O
narcotics	O
potentiated	O
by	O
poor	O
oral	O
intake	O
and	O
subsequent	O
___.	O
#)	O
Delirium,	B-Delirium
hypoactive:	O
suspect	O
AMS	B-Delirium
was	O
primarily	O
due	O
to	O
methadone	O
overdose	O
in	O
the	O
setting	O
___	O
and	O
impaired	O
narcotic	O
clearance.	O
Picture	O
was	O
likely	O
multifactorial;	O
that	O
is,	O
complicated	O
by	O
multiple	O
electrolyte	O
abnormalities,	O
hepatic	O
encephalopathy,	B-Delirium
and	O
constipation.	B-Constipation
Patient	O
was	O
initially	O
treated	O
with	O
empiric	O
Zosyn	O
for	O
possible	O
UTI,	B-Urinary_tract_infection
but	O
this	O
was	O
ultimately	O
discontinued,	O
as	O
sepsis	O
investigations	O
were	O
unrevealing.	O
Patient	O
had	O
a	O
small	O
amount	O
of	O
ascites,	O
but	O
her	O
exam	O
remained	O
inconsistent	O
with	O
SBP.	O
Head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
did	O
not	O
demonstrated	O
acute	O
intracranial	B-Intracranial_haemorrhage
pathology.	O
She	O
returned	O
to	O
baseline	O
mental	O
status	O
by	O
discharge.	O
#)	O
___	O
on	O
CKD:	O
Cr	O
3.4	O
upon	O
admission	O
(baseline	O
1.4-1.8).	O
Injury	O
was	O
thought	O
to	O
be	O
pre-renal	O
in	O
nature,	O
given	O
suboptimal	O
oral	O
intake.	O
Urine	O
output	O
and	O
creatinine	O
improved	O
with	O
fluids,	O
albeit	O
slowly,	O
suggesting	O
concomitant	O
ATN	O
or	O
intra-renal	O
injury.	O
Further	O
investigation	O
was	O
deemed	O
inconsistent	O
with	O
new	O
goals	O
of	O
care.	O
#)	O
Constipation,	B-Constipation
opioid-induced:	O
KUB	O
demonstrated	O
significant	O
amount	O
of	O
stool	O
upon	O
admission.	O
Home	O
lactulose	O
was	O
titrated	O
to	O
___	O
bowel	O
movements	O
per	O
day.	O
Resolution	O
seemingly	O
paralleled	O
return	O
to	O
baseline	O
mentation.	O
#)	O
DM1:	O
patient	O
had	O
one	O
asymptomatic	O
episode	O
of	O
___	O
___	O
due	O
to	O
poor	O
oral	O
intake	O
and	O
insulin	O
stacking	O
in	O
the	O
setting	O
of	O
___.	O
Home	O
insulin	O
glargine	O
and	O
ISS	O
were	O
accordingly	O
adjusted.	O
Home	O
basal	O
regimen	O
was	O
cautiously	O
reintroduced.	O
#)	O
Hypercalcemia:	O
improved	O
with	O
fluids	O
and	O
restoration	O
of	O
kidney	O
function.	O
Probably	O
due	O
to	O
immobility.	O
PTH	O
appropriately	O
low.	O
CXR	O
not	O
suggestive	O
of	O
tumor	O
and	O
consequent	O
hypercalcemia	O
of	O
malignancy.	O
No	O
protein	O
gap.	O
Further	O
investigation	O
for	O
multiple	O
myeloma	O
was	O
deemed	O
inconsistent	O
with	O
new	O
goals	O
of	O
care.	O
#)	O
Hyponatremia:	O
improved	O
with	O
judicious	O
fluids,	O
suggesting	O
hypovolemic	O
hyponatremia.	O
Probable	O
component	O
of	O
poor	O
solute	O
intake	O
too.	O
Urine	O
studies	O
equivocal.	O
#)	O
Hyperkalemia:	O
minor;	O
no	O
ECG	O
changes.	O
Due	O
to	O
___.	O
Improved	O
with	O
fluids	O
and	O
restoration	O
of	O
kidney	O
function.	O
#)	O
HTN:	O
intermittently	O
hypertensive	O
to	O
sBP	O
170;	O
asymptomatic.	O
Home	O
carvedilol	O
was	O
increased	O
to	O
12.5	O
QAM,	O
12.5	O
QPM	O
with	O
adequate	O
effect.	O
Home	O
clonidine,	O
amlodipine,	O
hydralazine,	O
Imdur	O
were	O
continued.	O
Home	O
lisinopril	O
was	O
held	O
in	O
the	O
setting	O
of	O
___.	O
#)	O
Goals	O
of	O
care:	O
after	O
discussion	O
with	O
patient	O
(when	O
coherent),	O
husband	O
(proxy),	O
palliative	O
care,	O
and	O
SW,	O
it	O
was	O
determined	O
that	O
frequent	O
re-admissions	O
and	O
generalized	O
aversion	O
to	O
hospitalization	O
do	O
not	O
align	O
with	O
her	O
preferences.	O
She	O
ultimately	O
prefers	O
to	O
remain	O
at	O
home	O
with	O
adequate	O
analgesia	O
for	O
her	O
chronic	O
left	O
leg/lumbar	O
back	O
pain.	O
Code	O
status	O
amended	O
to	O
DNR/DNI.	O
CHRONIC/STABLE	O
PROBLEMS:	O
#)	O
Back	O
pain/left	O
leg	O
pain:	O
patient	O
previously	O
on	O
methadone	O
5	O
mg	O
TID,	O
which	O
was	O
discontinued	O
by	O
PCP	O
for	O
long	O
QT.	O
It	O
was	O
learned	O
that	O
patient	O
subsequently	O
obtained	O
methadone	O
via	O
sharing	O
at	O
home.	O
Palliative	O
care	O
recommended	O
low-dose	O
opioid	O
as	O
needed	O
for	O
pain	O
management.	O
Patient	O
did	O
not	O
have	O
evidence	O
of	O
opioid	O
withdrawal.	O
#)	O
Normocytic,	O
normochromic	O
anemia:	O
suspect	O
patient	O
arrived	O
hemoconcentrated	O
from	O
poor	O
oral	O
intake.	O
Subsequent	O
decline	O
was	O
thus	O
due	O
to	O
hemodilution	O
after	O
volume	O
expansion.	O
.	O
.	O
Transitional	O
Issues	O
=============	O
[]Home	O
with	O
hospice	B-Lives_in_carehome
services	B-Has_carers
[]Consider	O
further	O
discontinuation	O
of	O
medicines	O
to	O
align	O
with	O
goals	O
of	O
care	O
.	O
.	O
.	O
Time	O
in	O
care	O
=============	O
[x]Greater	O
than	O
30	O
minutes	O
in	O
discharge-related	O
activities	O
including	O
patient	O
counseling,	O
patient	O
education	O
and	O
care	O
coordination	O
on	O
the	O
day	O
of	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
500	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
2.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
3.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Artificial	O
Tears	O
___	O
DROP	O
BOTH	O
EYES	O
PRN	O
dry	O
eyes	O
5.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
6.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
7.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
8.	O
Carvedilol	O
6.25	O
mg	O
PO	O
QAM	O
9.	O
Carvedilol	O
12.5	O
mg	O
PO	O
QPM	O
10.	O
CloNIDine	O
0.2	O
mg	O
PO	O
BID	O
11.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
12.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
13.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
DAILY	O
14.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
1	O
INH	O
IH	O
BID	O
15.	O
HydrALAZINE	O
100	O
mg	O
PO	O
Q8H	O
16.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
90	O
mg	O
PO	O
DAILY	O
17.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
DAILY	O
18.	O
Lidocaine	O
5%	O
Ointment	O
1	O
Appl	O
TP	O
BID	O
19.	O
Lisinopril	O
30	O
mg	O
PO	O
DAILY	O
20.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
21.	O
Ondansetron	O
ODT	O
4	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
22.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
23.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
constipation	B-Constipation
24.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
25.	O
BuPROPion	O
XL	O
(Once	O
Daily)	O
150	O
mg	O
PO	O
DAILY	O
26.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
27.	O
Combigan	O
(brimonidine-timolol)	O
0.2-0.5	O
%	O
ophthalmic	O
BID	O
28.	O
Miconazole	O
Powder	O
2%	O
1	O
Appl	O
TP	O
TID:PRN	O
axillary	O
rash	O
29.	O
Rosuvastatin	O
Calcium	O
10	O
mg	O
PO	O
QPM	O
30.	O
travoprost	O
0.004	O
%	O
ophthalmic	O
QPM	O
31.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
DAILY	O
32.	O
Nitrofurantoin	O
(Macrodantin)	O
100	O
mg	O
PO	O
DAILY	O
33.	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
34.	O
Lactulose	O
30	O
mL	O
PO	O
TID	O
constipation	B-Constipation
35.	O
Glargine	O
6	O
Units	O
Breakfast	O
Glargine	O
8	O
Units	O
Bedtime	O
36.	O
NovoLOG	O
(insulin	O
aspart)	O
100	O
unit/mL	O
subcutaneous	O
per	O
sliding	O
scale	O
with	O
meals	O
Discharge	O
Medications:	O
1.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
RX	O
*docusate	O
sodium	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
2.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Severe	O
RX	O
*oxycodone	O
[Oxaydo]	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Disp	O
#*12	O
Tablet	O
Refills:*0	O
3.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
1	O
tablet	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
4.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H	O
5.	O
Carvedilol	O
12.5	O
mg	O
PO	O
BID	O
6.	O
Glargine	O
2	O
Units	O
Breakfast	O
Glargine	O
6	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
7.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
8.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
9.	O
Artificial	O
Tears	O
___	O
DROP	O
BOTH	O
EYES	O
PRN	O
dry	O
eyes	O
10.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
11.	O
BuPROPion	O
XL	O
(Once	O
Daily)	O
150	O
mg	O
PO	O
DAILY	O
12.	O
CloNIDine	O
0.2	O
mg	O
PO	O
BID	O
13.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
14.	O
Combigan	O
(brimonidine-timolol)	O
0.2-0.5	O
%	O
ophthalmic	O
BID	O
15.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
1	O
INH	O
IH	O
BID	O
16.	O
HydrALAZINE	O
100	O
mg	O
PO	O
Q8H	O
17.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
90	O
mg	O
PO	O
DAILY	O
18.	O
Lactulose	O
30	O
mL	O
PO	O
TID	O
constipation	B-Constipation
19.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
DAILY	O
20.	O
Lidocaine	O
5%	O
Ointment	O
1	O
Appl	O
TP	O
BID	O
21.	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
22.	O
Miconazole	O
Powder	O
2%	O
1	O
Appl	O
TP	O
TID:PRN	O
axillary	O
rash	O
23.	O
Nitrofurantoin	O
(Macrodantin)	O
100	O
mg	O
PO	O
DAILY	O
24.	O
NovoLOG	O
(insulin	O
aspart)	O
100	O
unit/mL	O
subcutaneous	O
PER	O
SLIDING	O
SCALE	O
WITH	O
MEALS	O
25.	O
Ondansetron	O
ODT	O
4	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
26.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
27.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
constipation	B-Constipation
28.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
29.	O
travoprost	O
0.004	O
%	O
ophthalmic	O
QPM	O
30.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Delirium	B-Delirium
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Bedbound.	B-Bed_Chairbound
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___!	O
WHY	O
WERE	O
YOU	O
ADMITTED?	O
You	O
were	O
admitted	O
for	O
confusion.	B-Delirium
WHAT	O
HAPPENED	O
IN	O
THE	O
HOSPITAL?	O
You	O
were	O
given	O
fluids,	O
antibiotics,	O
and	O
medicines	O
to	O
help	O
you	O
move	O
your	O
bowels.	O
After	O
discussion	O
with	O
you	O
and	O
your	O
husband,	O
it	O
was	O
understood	O
you	O
wanted	O
to	O
remain	O
at	O
home	O
after	O
leaving	O
the	O
hospital.	O
You	O
met	O
with	O
our	O
palliative	O
care	O
doctors	O
and	O
decided	O
to	O
go	O
home	O
with	O
hospice	B-Lives_in_carehome
care	O
to	O
help	O
maximize	O
your	O
comfort	O
at	O
home.	O
WHAT	O
SHOULD	O
YOU	O
DO	O
AT	O
HOME?	O
-Please	O
let	O
your	O
hospice	B-Lives_in_carehome
nurse	O
know	O
if	O
you	O
have	O
pain	O
or	O
any	O
other	O
concern.	O
Thank	O
you	O
for	O
allowing	O
us	O
be	O
involved	O
in	O
your	O
care,	O
we	O
wish	O
you	O
all	O
the	O
best!	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

